Regulatory
As Psychedelic Medicines Near Approval, the FDA Weighs Safety Against Access
With psychedelic therapies advancing toward the market, a public FDA hearing wrestled with a central tension: how to protect patients without building an approval system so restrictive that few can actually use them.